StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
JSP-R.BK$1.77+0.00%
Fair $1.77+0.0%

JSP-R.BK

JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd.

Consumer Defensive / Packaged FoodsThailand

$1.77

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $1.77Fund rank 29/100 · Data gapFallback financials|
SA 49/C
F-Score: 7/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 19%

FCF escenarios

weak_data · normalized FCF $-133.2M · quality 51.3/100

Data gap 29/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 22/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

49/100

C

Piotroski

7/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · JSP-R.BKLocal privado en este navegador · JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$840M

P/E

88.5x

↑

EV/EBITDA

6.4x

↓

ROE

7.5%

↑

Gross Margin

40.1%

↑

Debt/Equity

0.42

↑
52-Week Range$2
$2$2

TradingView lightweight chart

JSP-R.BK price, volumen y niveles de valoración

Último $1.700Periodo -83.7%
Fair value: $1.770

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+30.2%

FCF CAGR

—

FCF margin

-14.7%

FCF / Net income

-2.19x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.01B · net income $67.9M · FCF $-148.6M

2022-FY → 2025-FY

Gross margin

40.1%+8.5% pts

Operating margin

11.4%+11.6% pts

Net margin

6.7%+7.4% pts

FCF margin

-14.7%+48.1% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$1.01B$1.01B$824.5M$575.6M$458.1M
Net Income$67.9M$67.9M$4.5M$29.3M$-3.1M
EBITDA$184.1M$184.1M$45.4M$97.3M$34.7M
EPS0.140.140.01-0.00-0.04
Gross Margin40.1%40.1%37.0%24.9%31.6%
Operating Margin11.4%11.4%12.7%-0.2%-0.2%
Net Margin6.7%6.7%0.5%5.1%-0.7%
Balance Sheet
Debt/Equity0.420.420.340.330.18
Current Ratio1.331.33———
Cash Flow
Free Cash Flow$-148.6M$-148.6M$75.0M$-133.2M$-287.7M
Returns
ROE7.5%7.5%0.5%3.4%-0.3%
Valuation
P/E88.5088.50210.56——
EV/EBITDA6.376.3727.7418.1752.94
P/B0.920.921.161.721.67
Growth & Yield
Revenue Growth22.5%22.5%43.2%25.7%—
EPS Growth1300.0%1300.0%350.0%90.0%—
Dividend Yield6.2%6.2%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

3.9%

fácil

EPS terminal req.

$0.16

Spread vs growth

1296.1%

5Y implied EPS CAGR

6.3%

razonable

EPS terminal req.

$0.19

Spread vs growth

1293.7%

10Y implied EPS CAGR

8.1%

razonable

EPS terminal req.

$0.31

Spread vs growth

1291.9%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +8.8%

Total return

+8.8%

Start / end P/E

165.7x → 12.1x

EPS bridge

0.01 → 0.14

Residual

-1204.7%

EPS growth+1300.0%
Multiple rerating-92.7%
Dividend+6.2%
Residual / FX / buybacks / cross-term-1204.7%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.